Prospective analysis of transcriptomic and genomic alterations increases the proportion of patients with solid cancer who are eligible for receiving matched therapies and shows promise in improving clinical outcomes.
- Jordi Rodon
- Jean-Charles Soria
- Razelle Kurzrock
